Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry

Clinica Chimica Acta

Volumn 418, Issue , 2013, Pages 86-90

  Zhang, Aihua ^a   Sun, Hui ^a   Yan, Guangli ^a   Han, Ying ^a   Ye, Yuan ^a   Wang, Xijun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Biomarkers; Glycocholic acid; Hepatocarcinoma; Metabolites; Metabolomics

Indexed keywords

GLYCOCHOLIC ACID;

ADULT; ARTICLE; BILE ACID SYNTHESIS; BILE SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID ANALYSIS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; METABOLOMICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEROL ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION; URINALYSIS;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLYCOCHOLIC ACID; HUMANS; LIVER NEOPLASMS; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS;

EID: 84873269399     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.12.024     Document Type: Article

References (19)

1. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455:1054-1056.
2. Arakaki A.K., Skolnick J., McDonald J.F. Marker metabolites can be therapeutic targets as well. Nature 2008, 456:443.
3. Zhang A., Sun H., Han Y., et al. Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst 2012, 137(18):4200-4208.
4. Backshall A., Sharma R., Clarke S.J., et al. Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine. Clin Cancer Res 2011, 17:3019-3028.
5. 1H-NMRS-based metabolomics study. Cancer Res 2009, 69:3731-3735.
6. Hirayama A., Kami K., Sugimoto M., et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 2009, 69(11):4918-4925.
7. Wang X., Zhang A., Han Y., et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 2012, 11(8):370-380.
8. Finley L.W., Lee J., Souza A., et al. Skeletal muscle transcriptional coactivator PGC-1α mediates mitochondrial, but not metabolic, changes during calorie restriction. Proc Natl Acad Sci U S A 2012, 109:2931-2936.
9. Wang X., Zhang A., Sun H. Urine metabolomics. Clin Chim Acta 2012, 10.1016/j.cca.2012.08.016.
10. Zhang A., Sun H., Wang X. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology 2012, 10.1002/hep.26130.
11. Patterson A.D., Maurhofer O., Beyoglu D., et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res 2011, 71:6590-6600.
12. Lee S.J., Trostel A., Le P., et al. Cellular stress created by intermediary metabolite imbalances. Proc Natl Acad Sci U S A 2009, 106:19515-19520.
13. Zhang A., Sun H., Wang X. Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem 2012, 404(4):1239-1245.
14. Sreekumar A., Poisson L.M., Rajendiran T.M., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457:910-914.
15. Zheng S., Yu M., Lu X., et al. Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression. Clin Chim Acta 2010, 411:204-209.
16. Woo H.M., Kim K.M., Choi M.H., et al. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta 2009, 400:63-69.
17. Wang X., Zhang A., Sun H. Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS 2012, 16(7-8):414-421.
18. Zhang A., Sun H., Dou S., et al. Metabolomics study on the hepatoprotective effect of scoparone using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Analyst 2013, 138:353-361.
19. Suhre K., Shin S.Y., Petersen A.K., et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2010, 477:54-60.